Cancer Biology & Genetics Program
The Viviane Tabar Lab
Research
I am a neurosurgeon-scientist and Chair of the Department of Neurosurgery. I have clinical expertise in the surgical management of brain tumors such as complex gliomas, meningiomas, and skull base tumors.
The lab is focused on two major themes: harnessing the potential of human pluripotent stem cells for brain repair and tumor modeling and studying glioma biology with a focus on tumor cell heterogeneity and the microenvironment.
Research Projects
Featured News
Publications
Berlin C, Lange K, Lekaye HC, Hopland K, Phillips S, Piao J, Tabar V. Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment. Neuro Oncol. 2020 April 2; 22(8): 1126-1137PMCID: PMC7594568.
Dincer Z, Piao J, Niu L, Ganat Y, Kriks S, Zimmer B, Shi S, Tabar V, Studer Let al. Specification of functional cranial placode derivatives from human pluripotent stem cells. Cell Rep. 2013;5(5):1387-1402. PMCID: PMC3887225
Funato K, Major T, Lewis PW, Allis CD, Tabar V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science. 2014 Dec 19;346(6216):1529-33. PMCID: PMC4995593
Funato K, Smith RC, Saito Y, Tabar V. Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma. Cell Stem Cell. 2021 Feb 17: S1934-5909(21)00053-9. PMCID: PMC8106629.
People
Viviane Tabar, MD
- Physician-scientist Viviane Tabar focuses on stem cells as tools for brain repair and for modeling brain cancer.
- MD, American University of Beirut
- 212-639-3006
- Office Phone
- View physician profile
- Physician profile
Members
- BA, Wesleyan University
Lab Alumni
Lab Affiliations
Achievements
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
Career Opportunities
Get in Touch
-
Office Phone
-
Office Fax
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Viviane Tabar discloses the following relationships and financial interests:
-
American University of Beirut
Fiduciary Role/Position
-
BlueRock Therapeutics
Intellectual Property Rights; Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.